The essential subject of Pharmaceutica 2019 is “Research and Innovations in Pharmaceutics and Novel Drug Delivery Systems”. This unique prospect that we outspread to our speakers and attendees are not being offered by any other conference organizers. Through the abstracts and research profiles of our respected speakers and Organizing Committee Members getting global visibility which is an additional feature that our attendees would be receiving in addition to networking opportunities before, throughout and after the conference.
· Meet University circles and Corporate visionaries to get inspired
· Enlarge your knowledge and find explanations for problems
· Knowledge, Benchmarking and Make contacts offered at one place
· Forge connections and for global networking
· Highly planned and organized scientific programs
· Best Oral and Poster presentation ($699/ $399 resp.)
· Meet with new merchants and traders
· After participating in this conference, attendees should be able to discuss emerging problems in Pharmacy, Medicine and Healthcare field.
· Debate and apply recent research discoveries related to Pharmacy, Medicine and Healthcare.
· Reflect on the place of critical distance in Pharmacy, Medicine and Healthcare.
Currently, North America has surpassed all the continent in terms of novel drug delivery market in cancer research with a market share of around 38%. Due to excellent research & development in the field of drug delivery system, the exceptional adoption rate of new technologies, helpful reimbursement policy – North America has surpassed all the continents in terms of market share. Europe also holds the 2nd position with a very respective market share of around 29% due to a large number of the cancer patient, development of clinical research facilities, awareness & the novel therapy to the cancer patient.
But Asia is the fastest growing novel delivery market & it shows a huge elevation in growth curve during recent times due to vast research activities, awareness, new therapy procedure, increased no. of the cancer patient in China & Japan. Currently, it holds the 3rd position in the global market with a share of around 20% but in the future, it is expected to boost the market growth.
The total value of global NDDS market in 2016 was $4.31 Billion. The growth is boosted at a rate of 22.9% during the recent period according to CGAR report. The main key drivers of the market growth are a large investment in research & development section of NDDS, increasing no. of cancer patients, awareness, and alternative treatment method etc.
Here is the expected market growth of NDDS up to 2025
However, there are some limitations which ridiculously affect the growth of the novel delivery market. Lack of awareness, an inadequate fund for research & new technologies of NDDS, fear of habituating in alternative therapy technique retarded the speed of growth of novel drug delivery market. Especially the countries like Mexico, Australia, India mainly facing those type of situation.
Advanced Drug Delivery Systems:
Our conference “Pharmaceutica 2019” is going to be held in London, UK because London recently becomes the hub of NDDS research & development. A wide range of research works are done by the renowned scientist in London & this UK city has a large number of Pharmaceutical University, colleges & institution. A vast amount of pharmaceutical company & production house also situated in London. At last the main thing is that London has the supply of a sufficient amount of money & top-notch infrastructure for research work & production and development of the new product.
Related Societies UK: Royal Pharmaceutical Society, The National Pharmacy Association, United Kingdom Clinical Pharmacy Association, British Pharmacological Society, Epilepsy Society Pharmacy, British Pharmaceutical Students' Association, Commonwealth Pharmacist Association and British Society for the History of Pharmacy.
Related Societies Europe: Pharmaceutical Group of the European Union European Society of Clinical Pharmacy, European Association of Hospital Pharmacists, European Society of Oncology Pharmacy and European CF Pharmacy Group - European Cystic Fibrosis Society.
For more about the tracks, please click on it.
Track 01: Pharmaceutical Packaging
Track 02: Clinical Trials and Clinical Research
Track 03: Pharmaceutical Formulations
Track 05: Pharmacy Education and Practice
Track 06: Innovative Drug Delivery Technologies
Track 07: Nanotechnology in Drug Delivery
Track 08: Biologics & Biosimilars
Track 09: Drug Delivery: Devices and Equipments
Track 11: Drug Delivery Vehicles
Track 12: Drug Delivery Through BBB
Track 13: Protein, Peptide and Gene Drug Delivery
Track 14: Novel Vaccine Delivery System
Track 15: Herbal Novel Drug Delivery
Track 16: Drug Discovery and Development Obstacles
Track 17: Pharmaceutical Nanotechnology
Track 19: Recent Advances in Drug Delivery System
Track 20: Bio-Pharmaceutics
Track 21: Drug Targeting and Design
Track 22: Nanomedicine and Biomedical Applications
Track 23: Pharmaceutical Analysis
Track 24: Pharmacovigilance Significance and Scope
Track 25: Drug Safety
Track 26: Pharmacology
Track 27: Antibiotics
Track 28: Healthcare and Hospital Management
Track 29: ADME-Drug Chemistry
Track 30: Pharmacognosy